메뉴 건너뛰기




Volumn 3, Issue 5, 2009, Pages 533-546

Biomarkers in the diagnosis and early detection of pancreatic cancer

Author keywords

Biomarkers; Diagnosis; Genomics; Pancreatic cancer; Proteomics

Indexed keywords

BIOLOGICAL MARKER; CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CAVEOLIN 1; CHEMOKINE RECEPTOR CXCR2; CYCLIN D2; DJ 1 PROTEIN; GELATINASE B; GROWTH FACTOR; HEAT SHOCK PROTEIN 27; K RAS PROTEIN; KI 67 ANTIGEN; MASPIN; MUCIN; PLATELET DERIVED GROWTH FACTOR A; PROTEIN BCL 2; PROTEIN KINASE PIM 1; PROTEIN MDM2; PROTEIN P16; PROTEIN P27; PROTEIN P53; PROTEIN P73; PROTEIN RET; PROTEIN S 100; SODIUM GLUCOSE COTRANSPORTER 1; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR SP1; UNINDEXED DRUG; VASCULOTROPIN;

EID: 77953391822     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530050903117256     Document Type: Review
Times cited : (11)

References (124)
  • 1
    • 48949095214 scopus 로고    scopus 로고
    • Translational research in pancreatic cancer
    • Highlights from the '44th ASCO Annual Meeting'. Chicago, IL, USA. May 30-June 3, 2008
    • Saif MW. Translational research in pancreatic cancer. Highlights from the '44th ASCO Annual Meeting'. Chicago, IL, USA. May 30-June 3, 2008. JOP 2008;9(4):398-402
    • (2008) JOP , vol.9 , Issue.4 , pp. 398-402
    • Saif, M.W.1
  • 2
    • 35348864295 scopus 로고    scopus 로고
    • Pancreatic cancer: Pathogenesis, prevention and treatment
    • DOI 10.1016/j.taap.2006.11.007, PII S0041008X06004212
    • Sarkar FH, Banerjee S, Li Y. Pancreatic cancer: pathogenesis, prevention and treatment. Toxicol Appl Pharmacol 2007;224(3):326-336 (Pubitemid 47575667)
    • (2007) Toxicology and Applied Pharmacology , vol.224 , Issue.3 , pp. 326-336
    • Sarkar, F.H.1    Banerjee, S.2    Li, Y.3
  • 4
    • 42049116900 scopus 로고    scopus 로고
    • New aspects of regulatory signaling pathways and novel therapies in pancreatic cancer
    • Diamantidis M, Tsapournas G, Kountouras J, Zavos C. New aspects of regulatory signaling pathways and novel therapies in pancreatic cancer. Curr Mol Med 2008;8(1):12-37
    • (2008) Curr Mol Med , vol.8 , Issue.1 , pp. 12-37
    • Diamantidis, M.1    Tsapournas, G.2    Kountouras, J.3    Zavos, C.4
  • 5
    • 34548401651 scopus 로고    scopus 로고
    • Progress on molecular markers of pancreatic cancer
    • DOI 10.1097/MOG.0b013e3282ba5724, PII 0000157420070900000005
    • Grote T, Logsdon CD. Progress on molecular markers of pancreatic cancer. Curr Opin Gastroenterol 2007;23(5):508-514 (Pubitemid 47356736)
    • (2007) Current Opinion in Gastroenterology , vol.23 , Issue.5 , pp. 508-514
    • Grote, T.1    Logsdon, C.D.2
  • 6
    • 46949096082 scopus 로고    scopus 로고
    • Caveolin-1: A marker for pancreatic cancer diagnosis
    • DOI 10.1586/14737159.8.4.395
    • Tanase CP. Caveolin-1: a marker for pancreatic cancer diagnosis. Expert Rev Mol Diagn 2008;8(4):395-404 (Pubitemid 351962086)
    • (2008) Expert Review of Molecular Diagnostics , vol.8 , Issue.4 , pp. 395-404
    • Tanase, C.P.1
  • 7
    • 51349092847 scopus 로고    scopus 로고
    • Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients
    • Tian M, Cui YZ, Song GH, et al. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer 2008;8:241
    • (2008) BMC Cancer , vol.8 , pp. 241
    • Tian, M.1    Cui, Y.Z.2    Song, G.H.3
  • 8
    • 34547417096 scopus 로고    scopus 로고
    • Identifying Molecular Markers for the Early Detection of Pancreatic Neoplasia
    • DOI 10.1053/j.seminoncol.2007.05.003, PII S009377540700098X, Pancreatic Cancer
    • Goggins M. Identifying molecular markers for the early detection of pancreatic neoplasia. Semin Oncol 2007;34(4):303-310 (Pubitemid 47176618)
    • (2007) Seminars in Oncology , vol.34 , Issue.4 , pp. 303-310
    • Goggins, M.1
  • 9
    • 52749099544 scopus 로고    scopus 로고
    • Pancreatic cancer: A plea for good and comprehensive morphological studies
    • Algul H, Schmid RM. Pancreatic cancer: a plea for good and comprehensive morphological studies. Eur J Gastroenterol Hepatol 2008;20(8):713-715
    • (2008) Eur J Gastroenterol Hepatol , vol.20 , Issue.8 , pp. 713-715
    • Algul, H.1    Schmid, R.M.2
  • 11
    • 34547638469 scopus 로고    scopus 로고
    • Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer
    • Salek C, Benesova L, Zavoral M, et al. Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer. World J Gastroenterol 2007;13(27):3714-3720 (Pubitemid 47202169)
    • (2007) World Journal of Gastroenterology , vol.13 , Issue.27 , pp. 3714-3720
    • Salek, C.1    Benesova, L.2    Zavoral, M.3    Nosek, V.4    Kasperova, L.5    Ryska, M.6    Strnad, R.7    Traboulsi, E.8    Minarik, M.9
  • 12
    • 33646550512 scopus 로고    scopus 로고
    • Molecular biomarkers: Their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer
    • DOI 10.1158/1535-7163.MCT-06-0005
    • Jimeno A, Hidalgo M. Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer. Mol Cancer Ther 2006;5(4):787-796 (Pubitemid 43724577)
    • (2006) Molecular Cancer Therapeutics , vol.5 , Issue.4 , pp. 787-796
    • Jimeno, A.1    Hidalgo, M.2
  • 13
    • 61449119672 scopus 로고    scopus 로고
    • Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer
    • El Maalouf G, Le Tourneau C, Batty GN, et al. Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer. Cancer Treat Rev 2008;35(2):167-174
    • (2008) Cancer Treat Rev , vol.35 , Issue.2 , pp. 167-174
    • El Maalouf, G.1    Le Tourneau, C.2    Batty, G.N.3
  • 15
    • 36749038370 scopus 로고    scopus 로고
    • Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma
    • DOI 10.1007/s00534-006-1184-3
    • Fujioka S, Misawa T, Okamoto T, et al. Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg 2007;14(6):539-544 (Pubitemid 350201463)
    • (2007) Journal of Hepato-Biliary-Pancreatic Surgery , vol.14 , Issue.6 , pp. 539-544
    • Fujioka, S.1    Misawa, T.2    Okamoto, T.3    Gocho, T.4    Futagawa, Y.5    Ishida, Y.6    Yanaga, K.7
  • 16
    • 33947668471 scopus 로고    scopus 로고
    • Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
    • Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 2007;33(3):266-270
    • (2007) Eur J Surg Oncol , vol.33 , Issue.3 , pp. 266-270
    • Goonetilleke, K.S.1    Siriwardena, A.K.2
  • 19
    • 49749088333 scopus 로고    scopus 로고
    • Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: Accurate detection of CA19-9 levels in pancreatic cancer
    • Grote T, Siwak DR, Fritsche HA, et al. Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer. Proteomics 2008;8(15):3051-3060
    • (2008) Proteomics , vol.8 , Issue.15 , pp. 3051-3060
    • Grote, T.1    Siwak, D.R.2    Fritsche, H.A.3
  • 20
    • 33748941924 scopus 로고    scopus 로고
    • Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer
    • Kilic M, Gocmen E, Tez M, et al. Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer. Can J Surg 2006;49(4):241-244 (Pubitemid 44432800)
    • (2006) Canadian Journal of Surgery , vol.49 , Issue.4 , pp. 241-244
    • Kilic, M.1    Gocmen, E.2    Tez, M.3    Ertan, T.4    Keskek, M.5    Koc, M.6
  • 21
    • 31444447627 scopus 로고    scopus 로고
    • Predictors of cancer in patients with suspected pancreatic malignancy without a tissue diagnosis
    • DOI 10.1016/j.amjsurg.2005.08.029, PII S0002961005007440
    • Tessler DA, Catanzaro A, Velanovich V, et al. Predictors of cancer in patients with suspected pancreatic malignancy without a tissue diagnosis. Am J Surg 2006;191(2):191-197 (Pubitemid 43151265)
    • (2006) American Journal of Surgery , vol.191 , Issue.2 , pp. 191-197
    • Tessler, D.A.1    Catanzaro, A.2    Velanovich, V.3    Havstad, S.4    Goel, S.5
  • 22
    • 37849041071 scopus 로고    scopus 로고
    • Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head
    • Liao Q, Zhao YP, Yang YC, et al. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head. Hepatobiliary Pancreat Dis Int 2007;6(6):641-645
    • (2007) Hepatobiliary Pancreat Dis Int , vol.6 , Issue.6 , pp. 641-645
    • Liao, Q.1    Zhao, Y.P.2    Yang, Y.C.3
  • 23
    • 46949105194 scopus 로고    scopus 로고
    • TPS, CA 19-9, VEGF-A, and CEA as diagnostic and prognostic factors in patients with mass lesions in the pancreatic head
    • Sandblom G, Granroth S, Rasmussen IC. TPS, CA 19-9, VEGF-A, and CEA as diagnostic and prognostic factors in patients with mass lesions in the pancreatic head. Ups J Med Sci 2008;113(1):57-64
    • (2008) Ups J Med Sci , vol.113 , Issue.1 , pp. 57-64
    • Sandblom, G.1    Granroth, S.2    Rasmussen, I.C.3
  • 25
    • 1642475141 scopus 로고    scopus 로고
    • Inhibition of MUC4 Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis
    • DOI 10.1158/0008-5472.CAN-03-2636
    • Singh AP, Moniaux N, Chauhan SC, et al. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Res 2004;64(2):622-630 (Pubitemid 38120902)
    • (2004) Cancer Research , vol.64 , Issue.2 , pp. 622-630
    • Singh, A.P.1    Moniaux, N.2    Chauhan, S.C.3    Meza, J.L.4    Batra, S.K.5
  • 29
    • 0242329867 scopus 로고    scopus 로고
    • Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas
    • Stanton KJ, Sidner RA, Miller GA, et al. Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas. Am J Surg 2003;186(5):486-492
    • (2003) Am J Surg , vol.186 , Issue.5 , pp. 486-492
    • Stanton, K.J.1    Sidner, R.A.2    Miller, G.A.3
  • 30
    • 0033991167 scopus 로고    scopus 로고
    • Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer
    • Itakura J, Ishiwata T, Shen B, et al. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer. Int J Cancer 2000;85(1):27-34
    • (2000) Int J Cancer , vol.85 , Issue.1 , pp. 27-34
    • Itakura, J.1    Ishiwata, T.2    Shen, B.3
  • 33
    • 52349105475 scopus 로고    scopus 로고
    • Differential diagnosis of pancreatic tumors by molecular analysis of clinical specimens
    • Buchholz M, Kestler H, Gress TM. Differential diagnosis of pancreatic tumors by molecular analysis of clinical specimens. Pancreatology 2008;8(6):551-557
    • (2008) Pancreatology , vol.8 , Issue.6 , pp. 551-557
    • Buchholz, M.1    Kestler, H.2    Gress, T.M.3
  • 34
    • 17844377326 scopus 로고    scopus 로고
    • Proteomic profiling of pancreatic cancer for biomarker discovery
    • DOI 10.1074/mcp.R500004-MCP200
    • Chen R, Pan S, Brentnall TA, Aebersold R. Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteomics 2005;4(4):523-533 (Pubitemid 40590569)
    • (2005) Molecular and Cellular Proteomics , vol.4 , Issue.4 , pp. 523-533
    • Chen, R.1    Pan, S.2    Brentnall, T.A.3    Aebersold, R.4
  • 35
    • 59949091318 scopus 로고    scopus 로고
    • Assessment of soluble angiogenic markers in pancreatic cancer
    • Tanase CP, Raducan E, Dima SO, et al. Assessment of soluble angiogenic markers in pancreatic cancer. Biomarkers Med 2008;5:447-455
    • (2008) Biomarkers Med , vol.5 , pp. 447-455
    • Tanase, C.P.1    Raducan, E.2    Dima, S.O.3
  • 38
    • 21344472559 scopus 로고    scopus 로고
    • Usefulness of plasma vascular endothelial growth factor in the diagnosis of pancreatic carcinoma: Differential diagnosis, tumor progression, and patient survival
    • DOI 10.1097/01.mpa.0000166999.11889.2f
    • Kobayashi A, Yamaguchi T, Ishihara T, et al. Usefulness of plasma vascular endothelial growth factor in the diagnosis of pancreatic carcinoma: differential diagnosis, tumor progression, and patient survival. Pancreas 2005;31(1):74-78 (Pubitemid 40911506)
    • (2005) Pancreas , vol.31 , Issue.1 , pp. 74-78
    • Kobayashi, A.1    Yamaguchi, T.2    Ishihara, T.3    Ohshima, T.4    Baba, T.5    Shirai, Y.6    Tadenuma, H.7    Nakamura, K.8    Saisho, H.9
  • 39
    • 0034657029 scopus 로고    scopus 로고
    • High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma
    • DOI 10.1002/(SICI)1097-0142(20000515)88:10<2239::AID-CNCR6>3.0. CO;2-V
    • Seo Y, Baba H, Fukuda T, et al. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 2000;88(10):2239-2245 (Pubitemid 30247122)
    • (2000) Cancer , vol.88 , Issue.10 , pp. 2239-2245
    • Seo, Y.1    Baba, H.2    Fukuda, T.3    Takashima, M.4    Sugimachi, K.5
  • 42
    • 0036531923 scopus 로고    scopus 로고
    • Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer
    • Baker CH, Solorzano CC, Fidler IJ. Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res 2002;62(7):1996-2003 (Pubitemid 34408443)
    • (2002) Cancer Research , vol.62 , Issue.7 , pp. 1996-2003
    • Baker, C.H.1    Solorzano, C.C.2    Fidler, I.J.3
  • 43
    • 0038068122 scopus 로고    scopus 로고
    • Expressions of angiogenic factors in pancreatic ductal carcinoma: A correlative study with clinicopathologic parameters and patient survival
    • DOI 10.1097/00006676-200305000-00006
    • Kuwahara K, Sasaki T, Kuwada Y, et al. Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. Pancreas 2003;26(4):344-349 (Pubitemid 36529959)
    • (2003) Pancreas , vol.26 , Issue.4 , pp. 344-349
    • Kuwahara, K.1    Sasaki, T.2    Kuwada, Y.3    Murakami, M.4    Yamasaki, S.5    Chayama, K.6
  • 44
    • 55949086925 scopus 로고    scopus 로고
    • Serum vascular endothelial growth factor/ soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer
    • Chang YT, Chang MC, Wei SC, et al. Serum vascular endothelial growth factor/ soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer. Pancreas 2008;37(2):145-150
    • (2008) Pancreas , vol.37 , Issue.2 , pp. 145-150
    • Chang, Y.T.1    Chang, M.C.2    Wei, S.C.3
  • 45
    • 56249140810 scopus 로고    scopus 로고
    • Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes
    • Lang SA, Schachtschneider P, Moser C, et al. Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes. Mol Cancer Ther 2008;7(11):3509-3518
    • (2008) Mol Cancer Ther , vol.7 , Issue.11 , pp. 3509-3518
    • Lang, S.A.1    Schachtschneider, P.2    Moser, C.3
  • 47
    • 0037452997 scopus 로고    scopus 로고
    • Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum
    • Welsh JB, Sapinoso LM, Kern SG, et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci USA 2003;100(6):3410-3415
    • (2003) Proc Natl Acad Sci USA , vol.100 , Issue.6 , pp. 3410-3415
    • Welsh, J.B.1    Sapinoso, L.M.2    Kern, S.G.3
  • 52
    • 2442701601 scopus 로고    scopus 로고
    • Macrophage inhibitory cytokine-1: A novel biomarker for p53 pathway activation
    • Yang H, Filipovic Z, Brown D, et al. Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation. Mol Cancer Ther 2003;2(10):1023-1029
    • (2003) Mol Cancer Ther , vol.2 , Issue.10 , pp. 1023-1029
    • Yang, H.1    Filipovic, Z.2    Brown, D.3
  • 56
    • 34648817383 scopus 로고    scopus 로고
    • Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy
    • Hathurusinghe HR, Goonetilleke KS, Siriwardena AK. Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy. Ann Surg Oncol 2007;14(10):2714-2720
    • (2007) Ann Surg Oncol , vol.14 , Issue.10 , pp. 2714-2720
    • Hathurusinghe, H.R.1    Goonetilleke, K.S.2    Siriwardena, A.K.3
  • 57
    • 58149394924 scopus 로고    scopus 로고
    • Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer
    • Novotny I, Dite P, Dastych M, et al. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer. Hepatogastroenterology 2008;55(85):1475-1477
    • (2008) Hepatogastroenterology , vol.55 , Issue.85 , pp. 1475-1477
    • Novotny, I.1    Dite, P.2    Dastych, M.3
  • 59
    • 51849142755 scopus 로고    scopus 로고
    • Tumor M2 pyruvate kinase: A tumor marker and its clinical application in gastrointestinal malignancy
    • Hardt PD, Ewald N. Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy. Expert Rev Mol Diagn 2008;8(5):579-585
    • (2008) Expert Rev Mol Diagn , vol.8 , Issue.5 , pp. 579-585
    • Hardt, P.D.1    Ewald, N.2
  • 60
    • 34447503504 scopus 로고    scopus 로고
    • Tumor M2-pyruvate kinase as tumor marker in exocrine pancreatic cancer a meta-analysis
    • DOI 10.1097/mpa.0b013e3180537237, PII 0000667620070800000002
    • Kumar Y, Gurusamy K, Pamecha V, Davidson BR. Tumor M2-pyruvate kinase as tumor marker in exocrine pancreatic cancer a meta-analysis. Pancreas 2007;35(2):114-119 (Pubitemid 47075564)
    • (2007) Pancreas , vol.35 , Issue.2 , pp. 114-119
    • Kumar, Y.1    Gurusamy, K.2    Pamecha, V.3    Davidson, B.R.4
  • 67
    • 34548418914 scopus 로고    scopus 로고
    • A feat of metabolic proportions: Pdx1 orchestrates islet development and function in the maintenance of glucose homeostasis
    • Babu DA, Deering TG, Mirmira RG. A feat of metabolic proportions: Pdx1 orchestrates islet development and function in the maintenance of glucose homeostasis. Mol Genet Metab 2007;92(1-2):43-55
    • (2007) Mol Genet Metab , vol.92 , Issue.1-2 , pp. 43-55
    • Babu, D.A.1    Deering, T.G.2    Mirmira, R.G.3
  • 68
    • 48949120875 scopus 로고    scopus 로고
    • Expression patterns of epiplakin1 in pancreas, pancreatic cancer and regenerating pancreas
    • DOI 10.1111/j.1365-2443.2008.01196.x
    • Yoshida T, Shiraki N, Baba H, et al. Expression patterns of epiplakin1 in pancreas, pancreatic cancer and regenerating pancreas. Genes Cells 2008;13(7):667-678 (Pubitemid 352003836)
    • (2008) Genes to Cells , vol.13 , Issue.7 , pp. 667-678
    • Yoshida, T.1    Shiraki, N.2    Baba, H.3    Goto, M.4    Fujiwara, S.5    Kume, K.6    Kume, S.7
  • 70
    • 57449083498 scopus 로고    scopus 로고
    • The expression pattern of PDX-1, SHH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer
    • Quint K, Stintzing S, Alinger B, et al. The expression pattern of PDX-1, SHH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer. Pancreatology 2008;9(1-2):116-126
    • (2008) Pancreatology , vol.9 , Issue.1-2 , pp. 116-126
    • Quint, K.1    Stintzing, S.2    Alinger, B.3
  • 71
    • 20044388765 scopus 로고    scopus 로고
    • Tissue MicroArray analyses of pancreatic duodenal homeobox-1 in human cancers
    • DOI 10.1007/s00268-004-7823-4
    • Wang XP, Li ZJ, Magnusson J, Brunicardi FC. Tissue MicroArray analyses of pancreatic duodenal homeobox-1 in human cancers. World J Surg 2005;29(3):334-338 (Pubitemid 40768046)
    • (2005) World Journal of Surgery , vol.29 , Issue.3 , pp. 334-338
    • Wang, X.-P.1    Li, Z.-J.2    Magnusson, J.3    Brunicardi, F.C.4
  • 72
    • 55949107920 scopus 로고    scopus 로고
    • PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer
    • Liu S, Ballian N, Belaguli NS, et al. PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer. Pancreas 2008;37(2):210-220
    • (2008) Pancreas , vol.37 , Issue.2 , pp. 210-220
    • Liu, S.1    Ballian, N.2    Belaguli, N.S.3
  • 73
    • 34247607335 scopus 로고    scopus 로고
    • Maspin is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: A tissue microarray based study
    • DOI 10.1097/01.pai.0000203037.25791.21, PII 0012903920070300000009
    • Nash JW, Bhardwaj A, Wen P, Frankel WL. Maspin is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: a tissue microarray based study. Appl Immunohistochem Mol Morphol 2007;15(1):59-63 (Pubitemid 46673318)
    • (2007) Applied Immunohistochemistry and Molecular Morphology , vol.15 , Issue.1 , pp. 59-63
    • Nash, J.W.1    Bhardwaj, A.2    Wen, P.3    Frankel, W.L.4
  • 76
    • 55949135598 scopus 로고    scopus 로고
    • Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma
    • Cohen SJ, Alpaugh RK, Palazzo I, et al. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma. Pancreas 2008;37(2):154-158
    • (2008) Pancreas , vol.37 , Issue.2 , pp. 154-158
    • Cohen, S.J.1    Alpaugh, R.K.2    Palazzo, I.3
  • 78
    • 67749094835 scopus 로고    scopus 로고
    • Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma
    • Tanase CP, Dima S, Mihai M, et al. Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma. J Mol Histol 2009;40(1):23-29
    • (2009) J Mol Histol , vol.40 , Issue.1 , pp. 23-29
    • Tanase, C.P.1    Dima, S.2    Mihai, M.3
  • 79
    • 53649086945 scopus 로고    scopus 로고
    • Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: Implications for tumor progression and clinical outcome
    • Witkiewicz AK, Nguyen KH, Dasgupta A, et al. Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: implications for tumor progression and clinical outcome. Cell Cycle 2008;7(19):3021-3025
    • (2008) Cell Cycle , vol.7 , Issue.19 , pp. 3021-3025
    • Witkiewicz, A.K.1    Nguyen, K.H.2    Dasgupta, A.3
  • 80
    • 9744274000 scopus 로고    scopus 로고
    • Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer
    • DOI 10.1158/1078-0432.CCR-04-1107
    • Mehta K, Fok J, Miller FR, et al. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin Cancer Res 2004;10(23):8068-8076 (Pubitemid 39587548)
    • (2004) Clinical Cancer Research , vol.10 , Issue.23 , pp. 8068-8076
    • Mehta, K.1    Fok, J.2    Miller, F.R.3    Koul, D.4    Sahin, A.A.5
  • 81
    • 42249085070 scopus 로고    scopus 로고
    • Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells
    • DOI 10.1158/1078-0432.CCR-07-1533
    • Verma A, Guha S, Wang H, et al. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells. Clin Cancer Res 2008;14(7):1997-2005 (Pubitemid 351551108)
    • (2008) Clinical Cancer Research , vol.14 , Issue.7 , pp. 1997-2005
    • Verma, A.1    Guha, S.2    Wang, H.3    Fok, J.Y.4    Koul, D.5    Abbruzzese, J.6    Mehta, K.7
  • 82
    • 35648961927 scopus 로고    scopus 로고
    • Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas
    • DOI 10.1002/dc.20739
    • Zhao H, Mandich D, Cartun RW, Ligato S. Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas. Diagn Cytopathol 2007;35(11):700-704 (Pubitemid 350035041)
    • (2007) Diagnostic Cytopathology , vol.35 , Issue.11 , pp. 700-704
    • Zhao, H.1    Mandich, D.2    Cartun, R.W.3    Ligato, S.4
  • 85
    • 13844304889 scopus 로고    scopus 로고
    • LigAmp for sensitive detection of single-nucleotide differences
    • Shi C, Eshleman SH, Jones D, et al. LigAmp for sensitive detection of single-nucleotide differences. Nat Methods 2004;1(2):141-147
    • (2004) Nat Methods , vol.1 , Issue.2 , pp. 141-147
    • Shi, C.1    Eshleman, S.H.2    Jones, D.3
  • 86
    • 0036735913 scopus 로고    scopus 로고
    • Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: Clinical utility for diagnosis of pancreatic tumor
    • DOI 10.1016/S0002-9270(02)04337-X
    • Tada M, Komatsu Y, Kawabe T, et al. Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor. Am J Gastroenterol 2002;97(9):2263-2270 (Pubitemid 35052042)
    • (2002) American Journal of Gastroenterology , vol.97 , Issue.9 , pp. 2263-2270
    • Tada, M.1    Komatsu, Y.2    Kawabe, T.3    Sasahira, N.4    Isayama, H.5    Toda, N.6    Shiratori, Y.7    Omata, M.8
  • 88
    • 62549149007 scopus 로고    scopus 로고
    • CXCR2 and RET Single Nucleotide Polymorphisms in Pancreatic Cancer
    • Donahue TR, Hines OJ. CXCR2 and RET Single Nucleotide Polymorphisms in Pancreatic Cancer. World J Surg 2008;33(4):710-715
    • (2008) World J Surg , vol.33 , Issue.4 , pp. 710-715
    • Donahue, T.R.1    Hines, O.J.2
  • 89
    • 53949106060 scopus 로고    scopus 로고
    • Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival
    • Casneuf VF, Fonteyne P, Van Damme N, et al. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival. Cancer Invest 2008;26(8):852-859
    • (2008) Cancer Invest , vol.26 , Issue.8 , pp. 852-859
    • Casneuf, V.F.1    Fonteyne, P.2    Van Damme, N.3
  • 91
    • 53549129746 scopus 로고    scopus 로고
    • Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma
    • Jiang NY, Woda BA, Banner BF, et al. Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2008;17(7):1648-1652
    • (2008) Cancer Epidemiol Biomarkers Prev , vol.17 , Issue.7 , pp. 1648-1652
    • Jiang, N.Y.1    Woda, B.A.2    Banner, B.F.3
  • 92
    • 59449096031 scopus 로고    scopus 로고
    • Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation
    • Chen J, Li D, Killary AM, et al. Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. Ann Surg Oncol 2008;16(2):431-439
    • (2008) Ann Surg Oncol , vol.16 , Issue.2 , pp. 431-439
    • Chen, J.1    Li, D.2    Killary, A.M.3
  • 93
    • 58149173406 scopus 로고    scopus 로고
    • Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma
    • Reiser-erkan C, Erkan M, Pan Z, et al. Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. Cancer Biol Ther 2008;7(9):1352-1359
    • (2008) Cancer Biol Ther , vol.7 , Issue.9 , pp. 1352-1359
    • Reiser-erkan, C.1    Erkan, M.2    Pan, Z.3
  • 95
    • 42249105871 scopus 로고    scopus 로고
    • Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer
    • DOI 10.1158/1078-0432.CCR-07-1520
    • Okazaki T, Jiao L, Chang P, et al. Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer. Clin Cancer Res 2008;14(7):2042-2048 (Pubitemid 351551114)
    • (2008) Clinical Cancer Research , vol.14 , Issue.7 , pp. 2042-2048
    • Okazaki, T.1    Jiao, L.2    Chang, P.3    Evans, D.B.4    Abbruzzese, J.L.5    Li, D.6
  • 97
    • 52149123619 scopus 로고    scopus 로고
    • Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
    • Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008;321(5897):1801-1806
    • (2008) Science , vol.321 , Issue.5897 , pp. 1801-1806
    • Jones, S.1    Zhang, X.2    Parsons, D.W.3
  • 98
    • 64849092309 scopus 로고    scopus 로고
    • Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
    • Jones S, Hruban RH, Kamiyama M, et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 2009;324(5924):217
    • (2009) Science , vol.324 , Issue.5924 , pp. 217
    • Jones, S.1    Hruban, R.H.2    Kamiyama, M.3
  • 102
    • 26844512938 scopus 로고    scopus 로고
    • Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry
    • DOI 10.1021/pr050174l
    • Yu KH, Rustgi AK, Blair IA. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J Proteome Res 2005;4(5):1742-1751 (Pubitemid 41464802)
    • (2005) Journal of Proteome Research , vol.4 , Issue.5 , pp. 1742-1751
    • Yu, K.H.1    Rustgi, A.K.2    Blair, I.A.3
  • 105
    • 12944265461 scopus 로고    scopus 로고
    • Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins
    • Koomen JM, Shih LN, Coombes KR, et al. Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin Cancer Res 2005;11(3):1110-1118
    • (2005) Clin Cancer Res , vol.11 , Issue.3 , pp. 1110-1118
    • Koomen, J.M.1    Shih, L.N.2    Coombes, K.R.3
  • 106
    • 33847120804 scopus 로고    scopus 로고
    • Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling
    • DOI 10.1097/01.mpa.0000250128.57026.b2, PII 0000667620070300000006
    • Ehmann M, Felix K, Hartmann D, et al. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Pancreas 2007;34(2):205-214 (Pubitemid 46294796)
    • (2007) Pancreas , vol.34 , Issue.2 , pp. 205-214
    • Ehmann, M.1    Felix, K.2    Hartmann, D.3    Schnolzer, M.4    Nees, M.5    Vorderwulbecke, S.6    Bogumil, R.7    Buchler, M.W.8    Friess, H.9
  • 107
    • 38449115230 scopus 로고    scopus 로고
    • Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas
    • DOI 10.1136/jcp.2006.044735
    • Qi T, Han J, Cui Y, et al. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas. J Clin Pathol 2008;61(1):49-58 (Pubitemid 351158225)
    • (2008) Journal of Clinical Pathology , vol.61 , Issue.1 , pp. 49-58
    • Qi, T.1    Han, J.2    Cui, Y.3    Zong, M.4    Liu, X.5    Zhu, B.6
  • 108
    • 40549087581 scopus 로고    scopus 로고
    • MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers
    • Cazares LH, Diaz JI, Drake RR, Semmes OJ. MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers. Methods Mol Biol 2008;428:125-140
    • (2008) Methods Mol Biol , vol.428 , pp. 125-140
    • Cazares, L.H.1    Diaz, J.I.2    Drake, R.R.3    Semmes, O.J.4
  • 109
    • 53849144620 scopus 로고    scopus 로고
    • Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
    • Kulasingam V, Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol 2008;5(10):588-599
    • (2008) Nat Clin Pract Oncol , vol.5 , Issue.10 , pp. 588-599
    • Kulasingam, V.1    Diamandis, E.P.2
  • 110
    • 50249147732 scopus 로고    scopus 로고
    • MALDI imaging mass spectrometry for direct tissue analysis: A new frontier for molecular histology
    • Walch A, Rauser S, Deininger SO, Hofler H. MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology. Histochem Cell Biol 2008;130(3):421-434
    • (2008) Histochem Cell Biol , vol.130 , Issue.3 , pp. 421-434
    • Walch, A.1    Rauser, S.2    Deininger, S.O.3    Hofler, H.4
  • 111
    • 61849093752 scopus 로고    scopus 로고
    • Pancreatic cancer serum detection using a lectin/glyco-antibody array method
    • Li C, Simeone DM, Brenner DE, et al. Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J Proteome Res 2009;8(2):483-492
    • (2009) J Proteome Res , vol.8 , Issue.2 , pp. 483-492
    • Li, C.1    Simeone, D.M.2    Brenner, D.E.3
  • 112
    • 65249091988 scopus 로고    scopus 로고
    • Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells
    • Wu YM, Nowack D, Omenn G, Haab B. Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells. J Proteome Res 2009;8(4):1876-1886
    • (2009) J Proteome Res , vol.8 , Issue.4 , pp. 1876-1886
    • Wu, Y.M.1    Nowack, D.2    Omenn, G.3    Haab, B.4
  • 113
    • 33846467633 scopus 로고    scopus 로고
    • Epidermal growth factor receptor inhibition strategies in pancreatic cancer: Past, present and the future
    • Cohenuram M, Saif MW. Epidermal growth factor receptor inhibition strategies in pancreatic cancer: past, present and the future. JOP 2007;8(1):4-15 (Pubitemid 46157763)
    • (2007) Journal of the Pancreas , vol.8 , Issue.1 , pp. 4-15
    • Cohenuram, M.1    Saif, M.W.2
  • 114
    • 41449091030 scopus 로고    scopus 로고
    • Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis
    • Pham NA, Schwock J, Iakovlev V, et al. Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis. BMC Cancer 2008;8:43
    • (2008) BMC Cancer , vol.8 , pp. 43
    • Pham, N.A.1    Schwock, J.2    Iakovlev, V.3
  • 115
    • 58149250649 scopus 로고    scopus 로고
    • Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma
    • Liang JJ, Wang H, Rashid A, et al. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res 2008;14(21):7043-7049
    • (2008) Clin Cancer Res , vol.14 , Issue.21 , pp. 7043-7049
    • Liang, J.J.1    Wang, H.2    Rashid, A.3
  • 116
    • 0034813635 scopus 로고    scopus 로고
    • Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2
    • DOI 10.1006/bbrc.2001.4243
    • Yip-Schneider MT, Lin A, Marshall MS. Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2. Biochem Biophys Res Commun 2001;280(4):992-997 (Pubitemid 32924437)
    • (2001) Biochemical and Biophysical Research Communications , vol.280 , Issue.4 , pp. 992-997
    • Yip-Schneider, M.T.1    Lin, A.2    Marshall, M.S.3
  • 118
    • 49249095430 scopus 로고    scopus 로고
    • Inhibition of STAT3 Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells
    • Zhao S, Venkatasubbarao K, Lazor JW, et al. Inhibition of STAT3 Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells. Cancer Res 2008;68(11):4221-4228
    • (2008) Cancer Res , vol.68 , Issue.11 , pp. 4221-4228
    • Zhao, S.1    Venkatasubbarao, K.2    Lazor, J.W.3
  • 119
    • 33845524970 scopus 로고    scopus 로고
    • Transforming growth factor-β in cancer and metastasis
    • DOI 10.1007/s10555-006-9006-2, Special Issue on Pro-inflammatory Cytokines in Cancer
    • Jakowlew SB. Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 2006;25(3):435-457 (Pubitemid 44922360)
    • (2006) Cancer and Metastasis Reviews , vol.25 , Issue.3 , pp. 435-457
    • Jakowlew, S.B.1
  • 120
    • 33645075720 scopus 로고    scopus 로고
    • Hedgehog signaling in pancreas development and disease
    • Lau J, Kawahira H, Hebrok M. Hedgehog signaling in pancreas development and disease. Cell Mol Life Sci 2006;63(6):642-652
    • (2006) Cell Mol Life Sci , vol.63 , Issue.6 , pp. 642-652
    • Lau, J.1    Kawahira, H.2    Hebrok, M.3
  • 121
    • 34547830895 scopus 로고    scopus 로고
    • β-Catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer
    • DOI 10.1016/j.mehy.2007.01.069, PII S0306987707001545
    • Wang Z, Ma Q. Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer. Med Hypotheses 2007;69(4):816-820 (Pubitemid 47248125)
    • (2007) Medical Hypotheses , vol.69 , Issue.4 , pp. 816-820
    • Wang, Z.1    Ma, Q.2
  • 122
    • 45949086825 scopus 로고    scopus 로고
    • Surrogate biomarkers in evaluating response to anti-angiogenic agents: Focus on sunitinib
    • Deprimo SE, Bello C. Surrogate biomarkers in evaluating response to anti-angiogenic agents: focus on sunitinib. Ann Oncol 2007;18(Suppl 10):x11-19
    • (2007) Ann Oncol , vol.18 , Issue.SUPPL. 10
    • Deprimo, S.E.1    Bello, C.2
  • 123
  • 124
    • 27644549557 scopus 로고    scopus 로고
    • Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies
    • DOI 10.1097/01.mpa.0000175893.04660.1b
    • Mimeault M, Brand RE, Sasson AA, Batra SK. Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies. Pancreas 2005;31(4):301-316 (Pubitemid 41566878)
    • (2005) Pancreas , vol.31 , Issue.4 , pp. 301-316
    • Mimeault, M.1    Brand, R.E.2    Sasson, A.A.3    Batra, S.K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.